The article focuses on the approach to the molecular engineering of the recombinant adenovirus vectors (rAd5). rAd5 has the potential to circumvent anti-vector immunity. The author also provides proof-of-concept that viral vaccine vectors can be engineered to evade pre-existing immunity. The results give tribute to the application of modern immunology and structural biology to vaccine design.